Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress.

Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, Tsankova NM, Bolanos CA, Rios M, Monteggia LM, Self DW, Nestler EJ.

Science. 2006 Feb 10;311(5762):864-8.

4.

Aggression and defeat: persistent effects on cocaine self-administration and gene expression in peptidergic and aminergic mesocorticolimbic circuits.

Miczek KA, Covington HE 3rd, Nikulina EM Jr, Hammer RP.

Neurosci Biobehav Rev. 2004 Jan;27(8):787-802. Review.

PMID:
15019428
5.

Ethanol-responsive brain region expression networks: implications for behavioral responses to acute ethanol in DBA/2J versus C57BL/6J mice.

Kerns RT, Ravindranathan A, Hassan S, Cage MP, York T, Sikela JM, Williams RW, Miles MF.

J Neurosci. 2005 Mar 2;25(9):2255-66.

6.

BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.

Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P.

Nature. 2001 May 3;411(6833):86-9.

PMID:
11333982
7.

Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action.

Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ.

Nat Neurosci. 2006 Apr;9(4):519-25. Epub 2006 Feb 26.

PMID:
16501568
8.

Short- and long-term effects of intermittent social defeat stress on brain-derived neurotrophic factor expression in mesocorticolimbic brain regions.

Fanous S, Hammer RP Jr, Nikulina EM.

Neuroscience. 2010 May 19;167(3):598-607. doi: 10.1016/j.neuroscience.2010.02.064. Epub 2010 Mar 3.

9.

Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions.

Molteni R, Calabrese F, Bedogni F, Tongiorgi E, Fumagalli F, Racagni G, Riva MA.

Int J Neuropsychopharmacol. 2006 Jun;9(3):307-17. Epub 2005 Jul 22.

PMID:
16035958
10.

Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments.

Lammers CH, Diaz J, Schwartz JC, Sokoloff P.

Mol Psychiatry. 2000 Jul;5(4):378-88.

PMID:
10889548
11.

Acute social defeat reduces neurotrophin expression in brain cortical and subcortical areas in mice.

Pizarro JM, Lumley LA, Medina W, Robison CL, Chang WE, Alagappan A, Bah MJ, Dawood MY, Shah JD, Mark B, Kendall N, Smith MA, Saviolakis GA, Meyerhoff JL.

Brain Res. 2004 Oct 29;1025(1-2):10-20.

PMID:
15464739
12.

Intra-VTA adenosine A1 receptor activation blocks morphine stimulation of motor behavior and cortical and limbic Fos immunoreactivity.

Kaplan GB, Leite-Morris KA, Klufas MA, Fan W.

Eur J Pharmacol. 2009 Jan 14;602(2-3):268-76. doi: 10.1016/j.ejphar.2008.10.052. Epub 2008 Nov 9.

PMID:
19027733
13.

Role of accumbens BDNF and TrkB in cocaine-induced psychomotor sensitization, conditioned-place preference, and reinstatement in rats.

Bahi A, Boyer F, Chandrasekar V, Dreyer JL.

Psychopharmacology (Berl). 2008 Aug;199(2):169-82. doi: 10.1007/s00213-008-1164-1. Epub 2008 Jun 13. Erratum in: Psychopharmacology (Berl). 2008 Sep;200(1):155. Chandrasekar, Vijay [added].

PMID:
18551281
14.

SKF83959 produces antidepressant effects in a chronic social defeat stress model of depression through BDNF-TrkB pathway.

Jiang B, Wang F, Yang S, Fang P, Deng ZF, Xiao JL, Hu ZL, Chen JG.

Int J Neuropsychopharmacol. 2014 Dec 7;18(6). pii: pyu096. doi: 10.1093/ijnp/pyu096.

15.

Intermittent social defeat stress enhances mesocorticolimbic ΔFosB/BDNF co-expression and persistently activates corticotegmental neurons: implication for vulnerability to psychostimulants.

Nikulina EM, Lacagnina MJ, Fanous S, Wang J, Hammer RP Jr.

Neuroscience. 2012 Jun 14;212:38-48. doi: 10.1016/j.neuroscience.2012.04.012. Epub 2012 Apr 19.

16.

Biphasic change in BDNF gene expression following antidepressant drug treatment explained by differential transcript regulation.

Khundakar AA, Zetterström TS.

Brain Res. 2006 Aug 23;1106(1):12-20. Epub 2006 Jul 13.

PMID:
16842762
17.

Antidepressant actions of histone deacetylase inhibitors.

Covington HE 3rd, Maze I, LaPlant QC, Vialou VF, Ohnishi YN, Berton O, Fass DM, Renthal W, Rush AJ 3rd, Wu EY, Ghose S, Krishnan V, Russo SJ, Tamminga C, Haggarty SJ, Nestler EJ.

J Neurosci. 2009 Sep 16;29(37):11451-60. doi: 10.1523/JNEUROSCI.1758-09.2009.

18.
19.

Brain-derived neurotrophic factor regulates hedonic feeding by acting on the mesolimbic dopamine system.

Cordeira JW, Frank L, Sena-Esteves M, Pothos EN, Rios M.

J Neurosci. 2010 Feb 17;30(7):2533-41. doi: 10.1523/JNEUROSCI.5768-09.2010.

20.

Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants.

Larsen MH, Hay-Schmidt A, Rønn LC, Mikkelsen JD.

Eur J Pharmacol. 2008 Jan 14;578(2-3):114-22. Epub 2007 Sep 26.

PMID:
17950272
Items per page

Supplemental Content

Write to the Help Desk